Complaints Status

 Received
 Under Process
45
 Resolved
45
 Rejected
45

FICCI POLICY ON HANDLING COMPLAINTS UNDER THE UCPMP

Department of Pharmaceutical’s efforts has recently announced the Uniform Code for Pharmaceutical Marketing Practices UCPMP 2024, that introduces a framework to regulate interactions between pharmaceutical companies and healthcare professionals, with a focus on preventing undue influence on prescription practices. UCPMP is a code that governs the interaction between the industry and healthcare practitioners (HCPs/doctors) in India. The UCPMP 2024 replaces the UCPMP 2015 and is applicable to both pharma and medical device companies. In the paragraphs below, we have summarized the business-critical changes between UCPMP 2024 and UCPMP 2015. The expression ‘company’ refers to both pharma and medical device companies, unless the context suggests otherwise. View More

FICCI Policy on Handling Complaints under the UCPMP

DOWNLOAD

Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) – 2024

DOWNLOAD

Ethics Committee for Pharma Marketing Practices (ECPMP) Enclosed 2024

DOWNLOAD

Format for Self-Declaration for FY 2024-25

DOWNLOAD

Quarterly report for F.Y. 23-24

DOWNLOAD

SELF-DECLARATION FOR FY 2024-25

Kenvue

DOWNLOAD

biocon biologics

DOWNLOAD

GlaxoSmithKline Asia Pvt Ltd

DOWNLOAD

Takeda

DOWNLOAD

GRIFOLS

DOWNLOAD

ROCHE

DOWNLOAD

PIRAMAL

DOWNLOAD

DABUR

DOWNLOAD

Contact us

Praveen K Mittal
Assistant Secretary General
Email: lifesciences@ficci.com

FICCI, Federation House,
Tansen Marg,
New Delhi, 110001